Chemoinformaics analysis of 1-O-HEXADECYL 2-O-PROP-2-ENYL OXALATE
| Molecular Weight | 354.531 | nRot | 17 |
| Heavy Atom Molecular Weight | 316.227 | nRig | 7 |
| Exact Molecular Weight | 354.277 | nRing | 0 |
| Solubility: LogS | -2.979 | nHRing | 0 |
| Solubility: LogP | 3.079 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 63.6161 |
| nHD | 0 | BPOL | 43.3299 |
| QED | 0.662 |
| Synth | 1.411 |
| Natural Product Likeliness | -0.136 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.32 |
| MDCK | 0.0000401 |
| BBB | 0.687 |
| PPB | 0.883076 |
| VDSS | 1.031 |
| FU | 0.128871 |
| CYP1A2-inh | 0.98 |
| CYP1A2-sub | 0.31 |
| CYP2c19-inh | 0.931 |
| CYP2c19-sub | 0.24 |
| CYP2c9-inh | 0.468 |
| CYP2c9-sub | 0.335 |
| CYP2d6-inh | 0.025 |
| CYP2d6-sub | 0.154 |
| CYP3a4-inh | 0.033 |
| CYP3a4-sub | 0.366 |
| CL | 13.241 |
| T12 | 0.89 |
| hERG | 0.132 |
| Ames | 0.067 |
| ROA | 0.072 |
| SkinSen | 0.576 |
| Carcinogencity | 0.343 |
| EI | 0.977 |
| Respiratory | 0.04 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.66085 |